White Sox's Mike Clevinger exits start with sore right biceps

ESPN logo
Thursday, June 15, 2023

LOS ANGELES -- Chicago White Sox pitcher Mike Clevinger left his start against the Los Angeles Dodgers in the fifth inning Wednesday night because of right biceps soreness.



The right-hander exited the field in apparent physical discomfort with two outs. He will be re-evaluated Thursday.




"I felt my biceps grab and never really felt something like that," Clevinger said after the White Sox won 8-4. "It kind of scared me, but got back in the training room, did some testing. The testing went all right."



Clevinger was pitching to J.D. Martinez when he kicked his right leg high and the momentum spun him around with his right arm twisting in a different direction. Clevinger nearly went down to his knees, using his left hand to keep himself on his feet.



He was replaced by Gregory Santos with the White Sox leading 2-0.



An inning later, White Sox manager Pedro Grifol was ejected for the third time this season after arguing with home plate umpire Pat Hoberg and crew chief Brian O'Nora in the sixth.



Grifol said he was upset because he didn't get a chance to challenge a play in which pinch-hitter Miguel Vargas was safe at second and Chris Taylor scored to make it 2-all.




"I like to get a look at almost every single play and we had plenty of time on the clock. I went back and looked at it," Grifol said. "They said I didn't have my hand up. I was making eye contact with the first-base umpire."



Clevinger, making his 12th start of the season, gave up three hits, struck out five and walked two on 77 pitches.



He was on the injured list from May 21 to June 2 with right wrist inflammation, missing two starts. Clevinger has appeared in just 42 games since the start of the 2020 season. The 32-year-old missed the entire 2021 season while recovering from his second Tommy John surgery. He had his first surgery in 2012.



The Associated Press contributed to this report.



Related Video

Copyright © 2024 ESPN Internet Ventures. All rights reserved.